PRO Therapeutics
PrivateLast Round
Seed
Dec 5, 2024
Total Funding Raised
$1.8M
Company Overview
PRO Therapeutics, LLC is a regenerative medicine company that develops and commercializes tissue-engineered grafts for soft tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PRO Therapeutics Comparables
Compare PRO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tetrous | 85% | |
| Atreon Orthopedics | 82% | |
| Zimmer Biomet | 77% | |
PRO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2024 | ||||
| Grant | Jul 17, 2023 |
PRO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Partnerships | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 1194% MoM, from 33 to 427.
- Dec 5, 2024
Seed round raised with Innovation Partnerships participating.
PRO Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PRO Therapeutics's valuation, stock price, and market status.